{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:44:39Z","timestamp":1787946279591,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.trim.2021.101490","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T18:18:10Z","timestamp":1634926690000},"page":"101490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3\u00a0years: The road towards new recommendations"],"prefix":"10.1016","volume":"69","author":[{"given":"Maroun","family":"Abou-Jaoud\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"El Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Akiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Araman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.trim.2021.101490_bb0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2021.101490_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fimmu.2016.00575","article-title":"HLA mismatching strategies for solid organ transplantation\u2013a balancing act","volume":"7","author":"Zachary","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2021.101490_bb0015","first-page":"44","article-title":"Induction therapy in half-haplotype low-risk kidney transplant patients: impact on acute rejection, graft survival, infection, and surgical complications at 3 years","volume":"7","author":"Abou-Jaoud\u00e9","year":"2019","journal-title":"Am. J. Med. Sci. Med."},{"issue":"2","key":"10.1016\/j.trim.2021.101490_bb0020","first-page":"032","article-title":"Tailor-made induction therapy in \u2018low risk\u2019renal transplants; a South Asian perspective","volume":"3","author":"Nalaka","year":"2017","journal-title":"Arch. Clin. Nephrol."},{"issue":"1","key":"10.1016\/j.trim.2021.101490_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-015-0807-x","article-title":"PREventing delayed graft function by driving immunosuppressive InduCtion treatment (PREDICT-DGF): study protocol for a randomized controlled trial","volume":"16","author":"Chapal","year":"2015","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.trim.2021.101490_bb0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1517\/14712598.7.10.1583","article-title":"Daclizumab","volume":"7","author":"Mottershead","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.trim.2021.101490_bb0035","first-page":"1135","article-title":"A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin","volume":"125","author":"Wei","year":"2012","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.trim.2021.101490_bb0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/toxins6030869","article-title":"Monoclonal antibody therapy and renal transplantation: focus on adverse effects","volume":"6","author":"Zaza","year":"2014","journal-title":"Toxins"},{"issue":"19","key":"10.1016\/j.trim.2021.101490_bb0045","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.trim.2021.101490_bb0050","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2165\/00003495-200969110-00007","article-title":"Rabbit antithymocyte globulin (thymoglobulin\u00ae)","volume":"69","author":"Deeks","year":"2009","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.trim.2021.101490_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2021.101490_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1034\/j.1399-0012.2000.140104.x","article-title":"Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients","volume":"14","author":"Jamil","year":"2000","journal-title":"Clin. Transpl."},{"issue":"6","key":"10.1016\/j.trim.2021.101490_bb0080","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.trim.2021.101490_bb0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/11631300-000000000-00000","article-title":"Induction therapy in renal transplant recipients","volume":"72","author":"Wagner","year":"2012","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.trim.2021.101490_bb0090","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ndt\/gfr169","article-title":"Endorsement of the kidney disease improving global outcomes (KDIGO) guidelines on kidney transplantation: a European renal best practice (ERBP) position statement","volume":"26","author":"Heemann","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2021.101490_bb0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2021.101490_bb0100","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1111\/j.1399-0012.2012.01654.x","article-title":"Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients","volume":"26","author":"Lim","year":"2012","journal-title":"Clin. Transpl."},{"issue":"2","key":"10.1016\/j.trim.2021.101490_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.tp.0000269725.74189.b9","article-title":"Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades","volume":"84","author":"Opelz","year":"2007","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.trim.2021.101490_bb0110","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2021.101490_bb0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/bjs.1800810432","article-title":"Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation","volume":"81","author":"Beckingham","year":"1994","journal-title":"J. Br. Surg."},{"issue":"1","key":"10.1016\/j.trim.2021.101490_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00007890-199807150-00006","article-title":"Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function","volume":"66","author":"McKenna","year":"1998","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2021.101490_bb0125","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1600-6143.2004.00535.x","article-title":"Diminishing significance of HLA matching in kidney transplantation","volume":"4","author":"Su","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2021.101490_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.trim.2021.101490_bb0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TP.0b013e318298f9db","article-title":"Relative importance of HLA mismatch and donor age to graft survival in young kidney transplant recipients","volume":"96","author":"Foster","year":"2013","journal-title":"Transplantation"},{"issue":"5 Pt 1","key":"10.1016\/j.trim.2021.101490_bb0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-0012.1997.tb00836.x","article-title":"Significance of the donor age effect on kidney transplants","volume":"11","author":"Terasaki","year":"1997","journal-title":"Clin. Transpl."},{"issue":"5","key":"10.1016\/j.trim.2021.101490_bb0145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2215\/CJN.10860917","article-title":"HLA-DQ mismatching and kidney transplant outcomes","volume":"13","author":"Leeaphorn","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2021.101490_bb0150","first-page":"413","article-title":"The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxis","volume":"39","author":"Felipe","year":"2017","journal-title":"Br. J. Nephrol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:02:53Z","timestamp":1760810573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327421001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S0966327421001301"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2021.101490","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3\u00a0years: The road towards new recommendations","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2021.101490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101490"}}